• Je něco špatně v tomto záznamu ?

Strategy for NMR metabolomic analysis of urine in mouse models of obesity--from sample collection to interpretation of acquired data

H. Pelantová, M. Bugáňová, J. Anýž, B. Železná, L. Maletínská, D. Novák, M. Haluzík, M. Kuzma,

. 2015 ; 115 (-) : 225-35. [pub] 20150717

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16020408

The mouse model of monosodium glutamate induced obesity was used to examine and consequently optimize the strategy for analysis of urine samples by NMR spectroscopy. A set of nineteen easily detectable metabolites typical in obesity-related studies was selected. The impact of urine collection protocol, choice of (1)H NMR pulse sequence, and finally the impact of the normalization method on the detected concentration of selected metabolites were investigated. We demonstrated the crucial effect of food intake and diurnal rhythms resulting in the choice of a 24-hour fasting collection protocol as the most convenient for tracking obesity-induced increased sensitivity to fasting. It was shown that the Carr-Purcell-Meiboom-Gill (CPMG) experiment is a better alternative to one-dimensional nuclear Overhauser enhancement spectroscopy (1D-NOESY) for NMR analysis of mouse urine due to its ability to filter undesirable signals of proteins naturally present in rodent urine. Normalization to total spectral area provided comparable outcomes as did normalization to creatinine or probabilistic quotient normalization in the CPMG-based model. The optimized approach was found to be beneficial mainly for low abundant metabolites rarely monitored due to their overlap by strong protein signals.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020408
003      
CZ-PrNML
005      
20161010141954.0
007      
ta
008      
160722s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jpba.2015.06.036 $2 doi
024    7_
$a 10.1016/j.jpba.2015.06.036 $2 doi
035    __
$a (PubMed)26263053
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Pelantová, Helena $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague 4, Czech Republic; Department of Analytical Chemistry, Faculty of Science, Palacký University, 17. listopadu 1192/12, 771 46 Olomouc, Czech Republic.
245    10
$a Strategy for NMR metabolomic analysis of urine in mouse models of obesity--from sample collection to interpretation of acquired data / $c H. Pelantová, M. Bugáňová, J. Anýž, B. Železná, L. Maletínská, D. Novák, M. Haluzík, M. Kuzma,
520    9_
$a The mouse model of monosodium glutamate induced obesity was used to examine and consequently optimize the strategy for analysis of urine samples by NMR spectroscopy. A set of nineteen easily detectable metabolites typical in obesity-related studies was selected. The impact of urine collection protocol, choice of (1)H NMR pulse sequence, and finally the impact of the normalization method on the detected concentration of selected metabolites were investigated. We demonstrated the crucial effect of food intake and diurnal rhythms resulting in the choice of a 24-hour fasting collection protocol as the most convenient for tracking obesity-induced increased sensitivity to fasting. It was shown that the Carr-Purcell-Meiboom-Gill (CPMG) experiment is a better alternative to one-dimensional nuclear Overhauser enhancement spectroscopy (1D-NOESY) for NMR analysis of mouse urine due to its ability to filter undesirable signals of proteins naturally present in rodent urine. Normalization to total spectral area provided comparable outcomes as did normalization to creatinine or probabilistic quotient normalization in the CPMG-based model. The optimized approach was found to be beneficial mainly for low abundant metabolites rarely monitored due to their overlap by strong protein signals.
650    _2
$a zvířata $7 D000818
650    _2
$a novorozená zvířata $7 D000831
650    _2
$a biologické markery $x moč $7 D015415
650    _2
$a interpretace statistických dat $7 D003627
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a mužské pohlaví $7 D008297
650    12
$a metabolom $7 D055442
650    _2
$a metabolomika $x metody $7 D055432
650    _2
$a inbrední kmeny myší $7 D008815
650    _2
$a nukleární magnetická rezonance biomolekulární $x metody $7 D019906
650    _2
$a obezita $x metabolismus $7 D009765
650    _2
$a analýza hlavních komponent $7 D025341
650    _2
$a odběr biologického vzorku $7 D013048
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bugáňová, Martina $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague 4, Czech Republic; Faculty of Chemical Technology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague 6, Czech Republic.
700    1_
$a Anýž, Jiří $u Department of Cybernetics, Faculty of Electrical Engineering, Czech Technical University in Prague, Technická 2, 166 27 Prague 6, Czech Republic. $7 gn_A_00007643
700    1_
$a Železná, Blanka $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic. $7 xx0206931
700    1_
$a Maletínská, Lenka $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
700    1_
$a Novák, Daniel $u Department of Cybernetics, Faculty of Electrical Engineering, Czech Technical University in Prague, Technická 2, 166 27 Prague 6, Czech Republic.
700    1_
$a Haluzík, Martin $u 3rd Medical Department, 1st Faculty of Medicine, Charles University and General Faculty Hospital in Prague, U nemocnice 1, 128 08 Prague 2, Czech Republic.
700    1_
$a Kuzma, Marek $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague 4, Czech Republic.
773    0_
$w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 115, č. - (2015), s. 225-35
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26263053 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20161010142348 $b ABA008
999    __
$a ok $b bmc $g 1155078 $s 944936
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 115 $c - $d 225-35 $e 20150717 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
LZP    __
$a Pubmed-20160722
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace